Cargando…
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
OBJECTIVES: To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT. METHODS: MDADI questionnaires were collected at...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118191/ https://www.ncbi.nlm.nih.gov/pubmed/35587295 http://dx.doi.org/10.1007/s00455-022-10434-4 |
_version_ | 1784710461526114304 |
---|---|
author | Ursino, Stefano Calistri, Elisa De Felice, Francesca Bonomo, Pierluigi Desideri, Isacco Franco, Pierfrancesco Arcadipane, Francesca Colosimo, Caterina Mazzola, Rosario Maddalo, Marta Gonnelli, Alessandra Malfatti, Giulia Morganti, Riccardo Musio, Daniela Paiar, Fabiola |
author_facet | Ursino, Stefano Calistri, Elisa De Felice, Francesca Bonomo, Pierluigi Desideri, Isacco Franco, Pierfrancesco Arcadipane, Francesca Colosimo, Caterina Mazzola, Rosario Maddalo, Marta Gonnelli, Alessandra Malfatti, Giulia Morganti, Riccardo Musio, Daniela Paiar, Fabiola |
author_sort | Ursino, Stefano |
collection | PubMed |
description | OBJECTIVES: To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT. METHODS: MDADI questionnaires were collected at baseline and at 6 and 12 months after treatment. MDADI scores were categorized as follows: ≥ 80 “optimal,” 80–60 “adequate,” < 60 “poor” deglutition-related quality of life (QoL) group, and dichotomized as “optimal” vs “adequate/poor” for the analysis. A mean MDADI composite (MDADI-C) change of 10 points was considered as minimal clinically important difference (MCID). RESULTS: Sixty-three patients were enrolled of which 47 were considered for the analysis. At baseline, 26 (55%) were “optimal” and 21 (45%) were “adequate/poor.” The mean baseline MDADI-C score was 93.6 dropping to 81 at 6 months (p = 0.013) and slightly rising to 85.5 at 12 months (p = 0.321) for the “optimal” group. Indeed, the mean baseline MDADI-C score was 64.3 rising to 77.5 at 6 months (p = 0.006) and stabilizing at 76 at 12 months (p = 0.999) for the “adequate/poor” group. A statistically significant but not clinically relevant worsening of the MDADI-C score was reported for the “optimal” group, whereas both a statistically significant and clinically meaningful improvement of the MDADI-C score were reported for the “adequate/poor” group from before to post-treatment. CONCLUSION: Our results suggest a doubly clinical benefit of dose optimization to SWOARs to minimize the RT sequalae in patients with a baseline “optimal” deglutition-related QoL and to recover from cancer dysphagia in those with a baseline “adequate/poor” deglutition-related QoL. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00455-022-10434-4. |
format | Online Article Text |
id | pubmed-9118191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-91181912022-05-19 Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Ursino, Stefano Calistri, Elisa De Felice, Francesca Bonomo, Pierluigi Desideri, Isacco Franco, Pierfrancesco Arcadipane, Francesca Colosimo, Caterina Mazzola, Rosario Maddalo, Marta Gonnelli, Alessandra Malfatti, Giulia Morganti, Riccardo Musio, Daniela Paiar, Fabiola Dysphagia Original Article OBJECTIVES: To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT. METHODS: MDADI questionnaires were collected at baseline and at 6 and 12 months after treatment. MDADI scores were categorized as follows: ≥ 80 “optimal,” 80–60 “adequate,” < 60 “poor” deglutition-related quality of life (QoL) group, and dichotomized as “optimal” vs “adequate/poor” for the analysis. A mean MDADI composite (MDADI-C) change of 10 points was considered as minimal clinically important difference (MCID). RESULTS: Sixty-three patients were enrolled of which 47 were considered for the analysis. At baseline, 26 (55%) were “optimal” and 21 (45%) were “adequate/poor.” The mean baseline MDADI-C score was 93.6 dropping to 81 at 6 months (p = 0.013) and slightly rising to 85.5 at 12 months (p = 0.321) for the “optimal” group. Indeed, the mean baseline MDADI-C score was 64.3 rising to 77.5 at 6 months (p = 0.006) and stabilizing at 76 at 12 months (p = 0.999) for the “adequate/poor” group. A statistically significant but not clinically relevant worsening of the MDADI-C score was reported for the “optimal” group, whereas both a statistically significant and clinically meaningful improvement of the MDADI-C score were reported for the “adequate/poor” group from before to post-treatment. CONCLUSION: Our results suggest a doubly clinical benefit of dose optimization to SWOARs to minimize the RT sequalae in patients with a baseline “optimal” deglutition-related QoL and to recover from cancer dysphagia in those with a baseline “adequate/poor” deglutition-related QoL. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00455-022-10434-4. Springer US 2022-05-19 2023 /pmc/articles/PMC9118191/ /pubmed/35587295 http://dx.doi.org/10.1007/s00455-022-10434-4 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Ursino, Stefano Calistri, Elisa De Felice, Francesca Bonomo, Pierluigi Desideri, Isacco Franco, Pierfrancesco Arcadipane, Francesca Colosimo, Caterina Mazzola, Rosario Maddalo, Marta Gonnelli, Alessandra Malfatti, Giulia Morganti, Riccardo Musio, Daniela Paiar, Fabiola Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
title | Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
title_full | Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
title_fullStr | Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
title_full_unstemmed | Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
title_short | Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
title_sort | patient-reported outcomes after swallowing (swoars)-sparing imrt in head and neck cancers: primary results from a prospective study endorsed by the head and neck study group (hnsg) of the italian association of radiotherapy and clinical oncology (airo) |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118191/ https://www.ncbi.nlm.nih.gov/pubmed/35587295 http://dx.doi.org/10.1007/s00455-022-10434-4 |
work_keys_str_mv | AT ursinostefano patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT calistrielisa patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT defelicefrancesca patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT bonomopierluigi patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT desideriisacco patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT francopierfrancesco patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT arcadipanefrancesca patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT colosimocaterina patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT mazzolarosario patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT maddalomarta patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT gonnellialessandra patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT malfattigiulia patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT morgantiriccardo patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT musiodaniela patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo AT paiarfabiola patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo |